Randomized Controlled Clinical Trial of Blood-activating and Stasis-resolving Herbs in Treatment of DN:A Systematic Review and Meta-Analysis
Author:
Affiliation:
Fund Project:
摘要
|
图/表
|
访问统计
|
参考文献
|
相似文献
|
引证文献
|
资源附件
|
文章评论
摘要:
目的:探讨活血消癥中药辨证治疗糖尿病肾病(Diabetic Nephropathy,DN)的有效性及安全性。方法:检索5个主要的电子数据库(中文数据库:中国知网(CNKI)、万方、维普(VIP),英文数据库:Medline、CENTRAL),检索日期从建库至2016年7月。筛选纳入并Meta分析活血消癥中药治疗DN的随机对照试验(Randomized Controlled Trials,RCT)。结果:活血消癥中药对于改善患者24 h尿蛋白定量(quantitative test of 24 h urinary protein,24 hUTP)(MD=-0.08 g,95%CI=[-0.13,-0.03],I2=0%)和中医证候积分(MD=-3.82,95%CI=[-4.84,-2.79],I2=0%)疗效优于ACEI/ARB类药物。对于SCr和BUN的影响,组间差异无统计学意义。结论:活血消癥中药降低DN患者24 hUTP和改善临床症状疗效优于ACEI/ARB类药物。
Abstract:
To explore the efficacy and safety of blood-activating and stasis-resolving herbs in treatment of diabetic nephropathy (DN).Methods:A total of 5 major electronic databases were retrieved.Chinese databases include:CNKI,Wan Fang database,VIP database,English databases include:Medline,CENTRAL.Retrieve the date from inception date to July 2016.Meta-Analysis was used to analyze the randomized controlled trials (RCTs) in Chinese herbal medicine therapy for DN.Results:Blood-activating and stasis-resolving herbs is better than ACEI/ARB in improving 24 hUTP (MD=-0.08 g,95%CI=[-0.13,-0.03],I2=0%)and TCM syndrome scores (MD=-3.82,95%CI=[-4.84,-2.79],I2=0%).For the effects of SCr and BUN,there were no significant differences between the groups.Conclusion:Blood-activating and stasis-resolving herbs to reduce DN patients′ 24 hUTP and improve clinical symptoms is better than ACEI/ARB.